Intracellular uptake of a new boronated porphyrin EC032

Applied Radiation and Isotopes

Volumn 67, Issue 7-8 SUPPL., 2009, Pages

  Tsurubuchi, T ^a   Yamamoto, T ^a   Nakai, K ^a   Zaboronok, A ^a   Yoshida, F ^a   Miyakawa, M ^a   Shirakawa, M ^a   Yamamoto, Y ^a   Matsuda, M ^a   Matsumura, A ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

10B concentration; Boronated porphyrin; Fluorescence study; ICP AES

Indexed keywords

10B CONCENTRATION; BORON CONCENTRATIONS; BORONATED PORPHYRIN; FLUORESCENCE INTENSITIES; FLUORESCENCE STUDIES; FLUORESCENCE STUDY; ICP-AES; INTRACELLULAR UPTAKE; LINEAR CORRELATION; MEASURING METHOD;

ATOMIC EMISSION SPECTROSCOPY; BORON; BORON COMPOUNDS; CONCENTRATION (PROCESS); INDUCTIVELY COUPLED PLASMA; PORPHYRINS; TOXICITY;

FLUORESCENCE;

ANTINEOPLASTIC AGENT; BOROCAPTATE; EC 032; PORPHYRIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; GLIOMA CELL; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ANALYSIS; TUMOR CELL CULTURE;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MOLECULAR STRUCTURE; PORPHYRINS; RADIATION-SENSITIZING AGENTS; RATS;

EID: 67649410169     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2009.03.098     Document Type: Article

References (16)

1. Barth R.F., Yang W., Al-Madhoun A.S., Johnsamuel J., Byun Y., Chandra S., Smith D.R., Tjarks W., and Eriksson S. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors. Cancer Res. 64 1 (2004) 6287-6295
2. Callahan D.E., Forte T.M., Afzal S.M.j., Deen D.F., Kahl S.B., Bjornstad K.A., Bauer W.F., and Blakely E.A. Boronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels. Int. J. Radiat. Oncol. Biol. Phys. 45 3 (1999) 761-771
3. Ceberg C.P., Brun A., Kahl S.B., Koo M.S., Person B.R., and Salford L.G.A. A cooparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model. J. Neurosurg. 83 (1995) 86-92
4. Fairchild R.G., Kahl S.B., Laster B.H., J. Kalef-Ezra J., and Popenoe E.A. In vitro determination of uptake, retention, distribution, biological efficacy, toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides. Cancer Res. 50 (1990) 4860-4865
5. Hao E., Sibrian-Vazquez M., Serem W., Garno J.C., Fronczek F.R., and Vincente M.G.H. Synthesis, aggregation and cellular investigation of porphyrin-cobaltacarborane conjugates. Chem. Eur. J. 13 (2007) 9035-9042
6. Hill J.S., Kahl S.B., Kaye A.H., Stylli S.S., Koo M., Gonzales M.F., Vardaxis N.J., and Johhson C.I. Selective tumor uptake of boronated porphyrin in an animal model of cerebral glioma. PNAS 89 (1992) 1785-1789
7. Mares V., Baudysova M., Kvitek J., Hnatowicz V., Cervena J., Vacik J., and Folbergrova J. Accumulation of boron-10 in cell cultures exposed to ercaptododecaborate used for the neutron capture therapy. J. Pharmacol. Exp. Therapeutics. 262 (1992) 818-822
8. Mares V., Krajci D., and Lisa V. Subcellular targets of mercaptoborate (BSH), a carrier of 10B for neutron capture therapy (BNCT) of brain tumors. Physiol. Res. 52 5 (2003) 629-635
9. Matsumura A., Shibata Y., Yamamoto T., Yoshida F., Isobe T., Nakai K., Hayakawa Y., Kiri M., Shimojo N., Ono K., Sakata I., Nakajima S., Okumura M., and Nose T. A new boronated porphyrin (STA-BX909) for neutron capture therapy: an in vitro survival assay and in vivo tissue uptake study. Cancer Lett. 141 (1999) 203-209
10. Nguyen T., Brownell G.L., Holden S.A., and Teicher B.A. Intracellular distribution of various boron compounds for use in boron neutron capture therapy. Biochem. Pharmacol. 45 1 (1993) 147-155
11. Novick S., Laster B.H., and Quastel M.R. Postitive cooperativity in the cellular uptake of a boronated porphyrin. Int. J. Biochem. Cell Biol. 38 (2006) 1374-1381
12. Shibata Y., Matsumura A., Yoshida F., Yamamoto T., Nakai K., Nose T., Sakata I., and Nakajima S. Competitive uptake of porphyrin and LDL via the LDL receptor in glioma cell lines: flow cytometric analysis. Cancer Lett. 166 1 (2001) 79-87 10
13. Spizzirri P.G., Hill J.S., Kahl S.B., and Ghiggino K.P. Photophysics and intracellular distribution of a boronated porphyrin phototherapeutic agent. Photochem. Photobiol. 64 6 (1996) 975-983
14. Vincente M.G.H., Edwards B.F., Shetty S.J., Hou Y., and Boggan J.E. Syntheses and preliminary biological studies of four meso-tetra(nido-carboranylmethyl)phenylporphyrins. Bioorg. Med. Chem. 10 (2002) 481-492
15. Yamamoto T., Matsumura A., Shibata Y., Fujimori H., Nakai K., Yoshida F., Nose T., Sakata T., Nakajima S., and Miwa N. Manganese-metalloporphyrin (ATN-10) as a tumor-localizing agent: magnetic resonance imaging and inductively coupled plasma atomic emission spectroscopy study with experimental brain tumors. Neurosurgery 42 6 (1998) 1332-1338
16. Yoshida F., Matsumura A., Shibata Y., Yamamoto T., Nakauchi H., Okumura M., and Nose T. Cell cycle dependence of boron uptake from two boron compounds used for clinical neutron capture therapy. Cancer Lett. 187 1-2 (2002) 135-141 10